Reply to the Letter to the Editor, Endocrine Practice for "Role of Teplizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Managing Newly Diagnosed Type 1 Diabetes: An Updated Systematic Review and Meta-Analysis".

Nagendra, Lakshmi; Dutta, Deep; Mondal, Sunetra; Yadav, Ashmita; Aalpona, Fatema Tuz Zahura; Kamrul-Hasan, A B M

Nagendra, Lakshmi; Dutta, Deep; Mondal, Sunetra; Yadav, Ashmita; Aalpona, Fatema Tuz Zahura; Kamrul-Hasan, A B M.

Afiliação

Nagendra L; Department of Endocrinology, JSS Medical College, JSS Academy of Higher Education and Research, Mysore, India.
Dutta D; Department of Endocrinology, CEDAR Superspeciality Healthcare, Dwarka, New Delhi, India.
Mondal S; Department of Endocrinology, NRS Medical College, Kolkata, India.
Yadav A; Department of Neurosciences, Nobel Medical College and Teaching Hospital, Biratnagar, Nepal.
Aalpona FTZ; Department of Gyne & Obs, Khaliajuri Upazila Health Complex, Netrokona, Bangladesh.
Kamrul-Hasan ABM; Department of Endocrinology, Mymensingh Medical College, Mymensingh 2200, Bangladesh. Electronic address: rangassmc@gmail.com.

Endocr Pract ; 2024 Jul 09.

Article em En | MEDLINE | ID: mdl-38992797

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article